Search Results - "Orlewska, E"

Cost of Pharmacotherapy in Polish Patients With Rheumatoid Arthritis by Szafraniec-Burylo, S, Orlewska, E

Get full text

Health economics and health technology assessment in Central and Eastern Europe: a dose of reality by Gulácsi, L., Orlewska, E., Péntek, M.

“…It is an opinion widely shared, at least among health economics (HE) and health technology assessment (HTA) experts, that the need for HE and HTA is increasing…”
Get full text

The Impact of the Polish Human Insulin (Gensulin) on Public Payer’s Expenditure in 2001-2013 by Orlewski, J, Orlewski, P.M, Orlewska, E

Get full text

Loss of Productivity in Polish Patients with Rheumatoid Arthritis by Szafraniec-Burylo, S.I, Orlewska, E, Rupinski, R, Filipowicz-Sosnowska, A

Get full text

Resource Use Due to Disability in Polish Rheumatoid Arthritis Patients: Significant Increase of Transportation Needs and Home Visits by Szafraniec-Burylo, S.I, Orlewska, E, Rupinski, R, Filipowicz-Sosnowska, A

Get full text

Burden of Informal Care in Relation to Disease Activity and Disability in Polish Patients with Rheumatoid Arthritis by Szafraniec-Burylo, S.I, Orlewska, E, Rupinski, R, Filipowicz-Sosnowska, A

Get full text

PDB23 Budget Impact Analysis of the Reimbursement of Long-Acting Insulin Analogues in Poland by Orlewska, E, Gulacsi, L

Get full text

Health Care Resource Utilization and Costs Associated with Treatment of Polish Acromegalic Patients with Lanreotide Autogel 120 Mg – A Retrospective Observational Cohort Analysis by Orlewska, E, Kos-Kudla, B, Sowinski, J, Sworczak, K, Zgliczynski, W

Get full text

Assessment of Real-World Usage of Lanreotide (Somatuline Autogel) 120 Mg in Polish Acromegalic Patients – Results from 1 Year Prospective Phase of Lanro-Study by Orlewska, E, Kos-Kudla, B, Sowinski, J, Sworczak, K, Zgliczynski, W

Get full text

PCN121 Challenges in Conducting Pharmacoeconomic Analyses in Central and Eastern Europe – Case Study on Breast Cancer by Skoupá, J, Orlewska, E, Kalo, Z, Hájek, P

Get full text

Economic aspects in medical decision-making by Orlewska, E

Get full text

A prospective study of the financial costs of multiple sclerosis at different stages of the disease by Orlewska, E., Mierzejewski, P., Zaborski, J., Kruszewska, J., Wicha, W., Fryze, W., Drozdowski, W., Skibicka, I., Mirowska-Guzel, D., Czlonkowski, A., Czlonkowska, A.

“…The aim of our study was to estimate the costs of multiple sclerosis (MS) in Poland according to severity of disease. Total, direct and indirect costs were…”
Get full text

IDF2022-0254 Glutathione S-transferase P1 genetic variants influence the HbA1c level in diabetic patients by Klusek, J., Głuszek, S., Orlewska, K., Marzec, M.T., Wawszczak-Kasza, M., Madej, Ł., Witczak, B., Orlewska, E.

Get full text

PMS61 - Cost of Pharmacotherapy in Polish Patients With Rheumatoid Arthritis by Szafraniec-Burylo, S., Orlewska, E.

Get full text

Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices—Budget Impact Analysis by Mauskopf, Josephine A., PhD, Sullivan, Sean D., PhD, Annemans, Lieven, PhD, MSc, Caro, Jaime, MD, Mullins, C. Daniel, PhD, Nuijten, Mark, PhD, MBA, MD, Orlewska, Ewa, MD, PhD, Watkins, John, RPh, MPH, Trueman, Paul, MA, BA

“…Abstract Objective There is growing recognition that a comprehensive economic assessment of a new health-care intervention at the time of launch requires both…”
Get full text

PND65 - Direct Medical Costs of Multiple Sclerosis and Regional Diversity in Access to Disease-Modifying Therapies in Poland Between 2008-2016 by Orlewska, K, Sliwczynski, A, Brzozowska, M, Wierzba, W, Marczak, M, Orlewska, E

Get full text

Direct Medical Costs of Multiple Sclerosis and Regional Diversity in Access to Disease-Modifying Therapies in Poland Between 2008-2016 by Orlewska, K, Sliwczynski, A, Brzozowska, M, Wierzba, W, Marczak, M, Orlewska, E

“…OBJECTIVES: Analysis of the public payer's spending on the treatment of multiple sclerosis (MS) and regional diversity in access :o disease-modifying therapies…”
Get full text

PDB116 - The Impact of the Polish Human Insulin (Gensulin) on Public Payer’s Expenditure in 2001-2013 by Orlewski, J., Orlewski, P.M., Orlewska, E.

Get full text

PDB21 - Budget Impact Analysis of Lanreotide Autogel 120 Mg in the Treatment of Acromegaly in Poland by Orlewska, E, Kos-Kudla, B, Sowinski, J, Sworczak, K, Zgliczynski, W

Get full text

Real-World Comorbidities, Treatment Pattern and Cost of Patients with Acromegaly in Poland Based on Retrospective Analysis Of Administrative Claims Data by Sliwczynski, A, Brzozowska, M, Labenda, A, Orlewska, K, Milkowski, M, Orlewska, E

Get full text